ES2179044T3 - Compuestos de argatroban para utilizacion oftalmologica. - Google Patents

Compuestos de argatroban para utilizacion oftalmologica.

Info

Publication number
ES2179044T3
ES2179044T3 ES93104458T ES93104458T ES2179044T3 ES 2179044 T3 ES2179044 T3 ES 2179044T3 ES 93104458 T ES93104458 T ES 93104458T ES 93104458 T ES93104458 T ES 93104458T ES 2179044 T3 ES2179044 T3 ES 2179044T3
Authority
ES
Spain
Prior art keywords
argatroban
compounds
ophthalmological use
anterior chamber
fibrin formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93104458T
Other languages
English (en)
Inventor
Tomiya Mano
Jin Shiomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Application granted granted Critical
Publication of ES2179044T3 publication Critical patent/ES2179044T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA EL USO DE ARGATROBAN PARA LA PREPARACION DE UN MEDICAMENTO PARA PREVENIR LA FORMACION DE FIBRINA EN LA CAMARA ANTERIOR DE MAMIFEROS. EL MEDICAMENTO PREPARADO MEDIANTE EL USO DE ARGATROBAN PARA PREVENIR LA FORMACION DE FIBRINA EN LA CAMARA ANTERIOR PUEDE PRESENTARSE A MODO DE SOLUCION IRRIGADORA, GOTAS PARA EL OJO O INFUSION DE GOTEO.
ES93104458T 1992-03-18 1993-03-18 Compuestos de argatroban para utilizacion oftalmologica. Expired - Lifetime ES2179044T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6194792 1992-03-18

Publications (1)

Publication Number Publication Date
ES2179044T3 true ES2179044T3 (es) 2003-01-16

Family

ID=13185901

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93104458T Expired - Lifetime ES2179044T3 (es) 1992-03-18 1993-03-18 Compuestos de argatroban para utilizacion oftalmologica.

Country Status (9)

Country Link
EP (1) EP0565897B1 (es)
KR (1) KR100287991B1 (es)
CN (1) CN1066328C (es)
AT (1) ATE219673T1 (es)
AU (1) AU668710B2 (es)
CA (1) CA2091715A1 (es)
DE (1) DE69332055T2 (es)
ES (1) ES2179044T3 (es)
TW (1) TW225477B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
DE69417087T2 (de) * 1993-04-22 1999-07-15 Mitsubishi Chemical Corp., Tokio/Tokyo Wässrige Arzneizubereitungen enthaltend Argatroban und Cyclodextrin oder Coffein
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
JP2001213798A (ja) * 2000-01-27 2001-08-07 Mitsubishi-Tokyo Pharmaceuticals Inc 眼科手術補助剤
EP1948133B1 (en) 2005-09-01 2011-06-29 BAXTER INTERNATIONAL INC. (a Delaware corporation) Argatroban formulation comprising an acid as solubilizer
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
WO2022133182A1 (en) * 2020-12-18 2022-06-23 Chan Zuckerberg Biohub, Inc. Method of treating coronavirus infection

Also Published As

Publication number Publication date
EP0565897B1 (en) 2002-06-26
ATE219673T1 (de) 2002-07-15
CA2091715A1 (en) 1993-09-19
AU668710B2 (en) 1996-05-16
TW225477B (es) 1994-06-21
DE69332055T2 (de) 2002-12-19
EP0565897A1 (en) 1993-10-20
CN1066328C (zh) 2001-05-30
KR930019214A (ko) 1993-10-18
DE69332055D1 (de) 2002-08-01
AU3523893A (en) 1993-09-23
KR100287991B1 (ko) 2001-05-02
CN1080850A (zh) 1994-01-19

Similar Documents

Publication Publication Date Title
DK0490991T3 (da) Doseringsform til oral administration af hypoglykæmisk glipizid
DE69129921D1 (de) Behandlung von Katarakt mit 15-keto-Prostaglandinderivaten
EP0045617A3 (en) Pharmaceutical composition
TW234691B (es)
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
ATE319458T1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
EP0330049A3 (en) Factor XIII for the prevention of intraventricular hemorrhage
TW225477B (es)
DK0382381T3 (da) Behandling af leukocyt-dysfunktion med GM-CSF
USD323030S (en) Medical syringe for administering subcutaneous injections
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
ATE159427T1 (de) Anwendung des n-n-butyl-derivates von desoxynojirimycin zur herstellung eines arzneimittels zur inhibierung von hiv-virus
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ES292955Y (es) Un espejo para cuentagotas de aplicacion ocular
KR910019622A (ko) 안과용 상승적 병용으로 안고혈압의 치료
RU95113855A (ru) Способ консервативного лечения ожогов глаз
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ATE103810T1 (de) Waesseriges arzneimittel.
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
RU2070061C1 (ru) Головка безыгольного инъектора
Hong et al. Comparative Studies of Timolol and Pilocarpine in Normal Volunteers
ITGE930069A0 (it) Dispositivo ausiliario automatico per siringhe preriempite per facili-tare l'introduzione dell'ago nel corpo del paziente.
IT1238697B (it) Composizione farmaceutica a carattere di collirio ad azione antinfiammatoria e procedimento per la sua preparazione